肝细胞应激通过YAP/TAZ促进肝实质炎症与纤维化
该研究在小鼠多种遗传、代谢和肝损伤模型中操控肝细胞Hippo通路,发现表达YAP的肝细胞上调促纤维化与促炎蛋白,刺激肌成纤维细胞和免疫细胞扩增并加重纤维化;肝细胞特异性敲除YAP或YAP/TAZ则减轻炎症和纤维化,CYR61是其中关键趋化因子,且在高级别NASH患者肝组织中YAP/TAZ与CYR61水平直接相关。
要点
- 肝细胞YAP/TAZ激活通过上调CYR61等因子招募巨噬细胞,促进肝脏炎症和纤维化。
- 肝细胞特异性敲除YAP或YAP/TAZ可减轻CCl4损伤后的肌成纤维细胞扩增、炎症和纤维化。
- 高级别NASH患者肝组织中YAP/TAZ与CYR61水平呈直接相关。
核心结论
- 小鼠和人类肝损伤增加肝细胞中YAP/TAZ/CYR61水平,从而吸引巨噬细胞至肝脏促进炎症和纤维化。
研究设计与样本
- 研究使用多种遗传、代谢和肝损伤小鼠模型,操控肝细胞Hippo信号并观察对非实质细胞的影响。
- 采用肝细胞特异性YAP敲除和YAP/TAZ敲除小鼠,在CCl4损伤后评估肌成纤维细胞扩增、炎症和纤维化。
- 通过CYR61的体内功能获得和功能缺失实验验证其在YAP/TAZ背景下对肝纤维化和炎症的调控作用。
- 分析高级别非酒精性脂肪性肝炎患者肝组织中YAP/TAZ与CYR61水平的相关性。
主要发现
- 表达YAP的肝细胞快速且强力激活促纤维化蛋白(胶原I alpha 1链、TIMP1、PDGF-c、TGF-β2)和促炎因子(TNF、IL-1β)的表达。
- 表达YAP的肝细胞刺激肌成纤维细胞和免疫细胞扩增,随后出现 aggressive 肝纤维化。
- 肝细胞特异性YAP和YAP/TAZ敲除小鼠在CCl4损伤后,尽管坏死程度与对照相似,但肌成纤维细胞扩增有限、炎症较轻、纤维化减少。
- CYR61是肝损伤时肝细胞上调的趋化因子,在肝细胞特异性缺失YAP或TAZ的小鼠中表达显著降低。
- CYR61的体内功能获得和功能缺失实验表明,它是YAP/TAZ背景下控制肝纤维化和炎症的关键趋化因子。
临床怎么用
- 肝细胞YAP/TAZ/CYR61轴可作为抑制肝纤维化和炎症的潜在干预靶点。
- 肝细胞特异性YAP/TAZ缺失在坏死程度相似时仍减轻纤维化,提示靶向该通路可能独立于损伤程度发挥抗纤维化作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Activated hepatocytes are hypothesized to be a major source of signals that drive cirrhosis, but the biochemical pathways that convert hepatocytes into such a state are unclear. We examined the role of the Hippo pathway transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in hepatocytes to facilitate cell-cell interactions that stimulate liver inflammation and fibrosis. APPROACH AND RESULTS: Using a variety of genetic, metabolic, and liver injury models in mice, we manipulated Hippo signaling in hepatocytes and examined its effects in nonparenchymal cells to promote liver inflammation and fibrosis. YAP-expressing hepatocytes rapidly and potently activate the expression of proteins that promote fibrosis (collagen type I alpha 1 chain, tissue inhibitor of metalloproteinase 1, platelet-derived growth factor c, transforming growth factor β2) and inflammation (tumor necrosis factor, interleukin 1β). They stimulate expansion of myofibroblasts and immune cells, followed by aggressive liver fibrosis. In contrast, hepatocyte-specific YAP and YAP/TAZ knockouts exhibit limited myofibroblast expansion, less inflammation, and decreased fibrosis after CCl4 injury despite a similar degree of necrosis as controls. We identified cellular communication network factor 1 (CYR61) as a chemokine that is up-regulated by hepatocytes during liver injury but is expressed at significantly lower levels in mice with hepatocyte-specific deletion of YAP or TAZ. Gain-of-function and loss-of-function experiments with CYR61 in vivo point to it being a key chemokine controlling liver fibrosis and inflammation in the context of YAP/TAZ. There is a direct correlation between levels of YAP/TAZ and CYR61 in liver tissues of patients with high-grade nonalcoholic steatohepatitis. CONCLUSIONS: Liver injury in mice and humans increases levels of YAP/TAZ/CYR61 in hepatocytes, thus attracting macrophages to the liver to promote inflammation and fibrosis.
引用
- Mooring M, Fowl BH, Lum SZC, et al. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis. Hepatology. 2020. PMID: 31505040. doi:10.1002/hep.30928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。